Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 636

2.

Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.

Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA.

JAMA. 2019 Oct 8;322(14):1371-1380. doi: 10.1001/jama.2019.11982.

PMID:
31593271
3.

Prevalence of chronic respiratory disease in urban and rural Uganda.

Siddharthan T, Grigsby M, Morgan B, Kalyesubula R, Wise RA, Kirenga B, Checkley W.

Bull World Health Organ. 2019 May 1;97(5):318-327. doi: 10.2471/BLT.18.216523. Epub 2019 Mar 26.

4.

Do Baseline Asthma and Allergic Sensitization Characteristics Predict Responsiveness to Mouse Allergen Reduction?

Ahmed A, Sadreameli SC, Curtin-Brosnan J, Grant T, Phipatanakul W, Perzanowski M, Balcer-Whaley S, Peng R, Newman M, Cunningham A, Divjan A, Bollinger ME, Wise RA, Miller R, Chew G, Matsui EC.

J Allergy Clin Immunol Pract. 2019 Sep 11. pii: S2213-2198(19)30769-X. doi: 10.1016/j.jaip.2019.08.044. [Epub ahead of print]

PMID:
31520838
5.

Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.

Hinze AM, Lin CT, Hussien AF, Perin J, Venado A, Golden JA, Boin F, Brown RH, Wise RA, Wigley FM.

Rheumatology (Oxford). 2019 Aug 27. pii: kez341. doi: 10.1093/rheumatology/kez341. [Epub ahead of print]

PMID:
31504916
6.

The Obesity Paradox in COPD is Absent in US Never-Smokers.

Wu TD, Ejike C, Wise RA, McCormack MC, Brigham EP.

Am J Epidemiol. 2019 Sep 5. pii: kwz185. doi: 10.1093/aje/kwz185. [Epub ahead of print]

PMID:
31504124
7.

Misinterpretation of time-to-first event curves can lead to inappropriate treatment.

Hartley B, Criner GJ, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lipson DA, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Lettis S.

Eur Respir J. 2019 Sep 5;54(3). pii: 1900634. doi: 10.1183/13993003.00634-2019. Print 2019 Sep. No abstract available.

PMID:
31488584
8.

Should you let your child play football? What about soccer or hockey?

Ferraro FR, Cuccolo K, Wise RA.

Appl Neuropsychol Child. 2019 Sep 2:1-6. doi: 10.1080/21622965.2019.1654385. [Epub ahead of print]

PMID:
31476888
9.

Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD.

Sidhaye VK, Holbrook JT, Burke A, Sudini KR, Sethi S, Criner GJ, Fahey JW, Berenson CS, Jacobs MR, Thimmulappa R, Wise RA, Biswal S.

Respir Res. 2019 Aug 20;20(1):190. doi: 10.1186/s12931-019-1164-1.

10.

Obstructive Sleep Apnea and Airway Dimensions in COPD.

Koch AL, Brown RH, Woo H, Brooker AC, Paulin LM, Schneider H, Schwartz AR, Diette GB, Wise RA, Hansel NN, Putcha N.

Ann Am Thorac Soc. 2019 Aug 19. doi: 10.1513/AnnalsATS.201903-220RL. [Epub ahead of print] No abstract available.

PMID:
31425663
11.

Diffusing Capacity of Carbon Monoxide in Assessment of COPD.

Balasubramanian A, MacIntyre NR, Henderson RJ, Jensen RL, Kinney G, Stringer WW, Hersh CP, Bowler RP, Casaburi R, Han MK, Porszasz J, Barr RG, Make BJ, Wise RA, McCormack MC.

Chest. 2019 Jul 25. pii: S0012-3692(19)31377-7. doi: 10.1016/j.chest.2019.06.035. [Epub ahead of print]

PMID:
31352035
12.

Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results.

Gatto NM, Koralek DO, Bracken MB, Duggan WT, Lem J, Klioze S, Koch GG, Wise RA, Cohen RB, Jackson NC.

Diabetes Care. 2019 Sep;42(9):1708-1715. doi: 10.2337/dc18-2529. Epub 2019 Jul 22.

PMID:
31331907
13.

Self-medication as Part of Self-management Plans for Patients With COPD-Reply.

Aboumatar H, Wise RA.

JAMA. 2019 May 21;321(19):1937. doi: 10.1001/jama.2019.2076. No abstract available. Erratum in: JAMA. 2019 Oct 8;322(14):1419.

PMID:
31112255
14.

Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.

Wise RA, Chapman KR, Scirica BM, Bhatt DL, Daoud SZ, Zetterstrand S, Reisner C, Gil EG.

JAMA. 2019 May 7;321(17):1693-1701. doi: 10.1001/jama.2019.4973.

PMID:
31063575
15.

Identifying an at-risk population for poor asthma outcomes: Data from the American Lung Association Asthma Clinical Trials Registry.

Bose S, Henderson RJ, Rogers L, Casale T, Skloot G, Soler X, Wise RA, Que LG.

J Allergy Clin Immunol Pract. 2019 Apr 28. pii: S2213-2198(19)30397-6. doi: 10.1016/j.jaip.2019.04.024. [Epub ahead of print] No abstract available.

PMID:
31042562
16.

The health and social implications of household air pollution and respiratory diseases.

Simkovich SM, Goodman D, Roa C, Crocker ME, Gianella GE, Kirenga BJ, Wise RA, Checkley W.

NPJ Prim Care Respir Med. 2019 Apr 26;29(1):12. doi: 10.1038/s41533-019-0126-x. Review.

17.

Older age and obesity are associated with increased airway closure in response to methacholine in patients with asthma.

Kaminsky DA, Chapman DG, Holbrook JT, Henderson RJ, Sugar EA, Mastronarde J, Teague WG, Busk M, Sumino K, Dixon AE, Wise RA, Irvin CG.

Respirology. 2019 Jul;24(7):638-645. doi: 10.1111/resp.13496. Epub 2019 Mar 5.

PMID:
30838750
18.

Plasma cathelicidin and longitudinal lung function in current and former smokers.

Burkes RM, Astemborski J, Lambert AA, Brown TT, Wise RA, Kirk GD, Drummond MB.

PLoS One. 2019 Feb 27;14(2):e0212628. doi: 10.1371/journal.pone.0212628. eCollection 2019.

19.

Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.

Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF; COPDGene Investigators.

J Psychosom Res. 2019 Mar;118:18-26. doi: 10.1016/j.jpsychores.2019.01.002. Epub 2019 Jan 7.

PMID:
30782350
20.

Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.

Putcha N, Fawzy A, Paul GG, Lambert AA, Psoter KJ, Sidhaye VK, Woo J, Wells JM, Labaki WW, Doerschuk CM, Kanner RE, Han MK, Martinez C, Paulin LM, Martinez FJ, Wise RA, O'Neal WK, Barr RG, Hansel NN; SPIROMICS investigators.

Ann Am Thorac Soc. 2018 Jun;15(6):710-717. doi: 10.1513/AnnalsATS.201708-687OC.

21.

BMI but not central obesity predisposes to airway closure during bronchoconstriction.

Peters U, Subramanian M, Chapman DG, Kaminsky DA, Irvin CG, Wise RA, Skloot GS, Bates JHT, Dixon AE.

Respirology. 2019 Jun;24(6):543-550. doi: 10.1111/resp.13478. Epub 2019 Jan 29.

PMID:
30694011
22.

Frailty and Clinical Outcomes in Chronic Obstructive Pulmonary Disease.

Kennedy CC, Novotny PJ, LeBrasseur NK, Wise RA, Sciurba FC, Benzo RP.

Ann Am Thorac Soc. 2019 Feb;16(2):217-224. doi: 10.1513/AnnalsATS.201803-175OC.

PMID:
30433830
23.

Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.

Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA.

JAMA. 2018 Dec 11;320(22):2335-2343. doi: 10.1001/jama.2018.17933. Retraction in: JAMA. 2019 Oct 8;322(14):1417-1418.

24.

Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin.

You ZB, Wang B, Gardner EL, Wise RA.

Pharmacol Biochem Behav. 2019 Jan;176:53-56. doi: 10.1016/j.pbb.2018.11.001. Epub 2018 Nov 7.

PMID:
30414405
25.

Validation of the maximum symptom day among children with asthma.

Wu TD, Perzanowski M, Peng RD, Wise RA, Balcer-Whaley S, Newman M, Cunningham A, Phipatanakul W, Matsui EC, McCormack MC.

J Allergy Clin Immunol. 2019 Feb;143(2):803-805.e10. doi: 10.1016/j.jaci.2018.10.008. Epub 2018 Oct 19. No abstract available.

26.

Does Obesity Increase Respiratory Tract Infections in Patients with Asthma?

Tang M, Henderson RJ, Holbrook JT, Que LG, Mathews AM, Wise RA, Dixon AE, Peters SP, Rogers L, Smith LJ, Teague WG, Lang JE.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):954-961.e6. doi: 10.1016/j.jaip.2018.09.033. Epub 2018 Oct 9.

PMID:
30312805
27.

Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries.

Morgan BW, Grigsby MR, Siddharthan T, Chowdhury M, Rubinstein A, Gutierrez L, Irazola V, Miranda JJ, Bernabe-Ortiz A, Alam D, Wise RA, Checkley W.

J Allergy Clin Immunol. 2019 Apr;143(4):1598-1606. doi: 10.1016/j.jaci.2018.06.052. Epub 2018 Oct 4.

PMID:
30291842
28.

Environmental exposures and systemic hypertension are risk factors for decline in lung function.

Miele CH, Grigsby MR, Siddharthan T, Gilman RH, Miranda JJ, Bernabe-Ortiz A, Wise RA, Checkley W; CRONICAS Cohort Study Group.

Thorax. 2018 Dec;73(12):1120-1127. doi: 10.1136/thoraxjnl-2017-210477. Epub 2018 Jul 30.

PMID:
30061168
29.

Validation of the Saint George's Respiratory Questionnaire in Uganda.

Morgan BW, Grigsby MR, Siddharthan T, Kalyesubula R, Wise RA, Hurst JR, Kirenga B, Checkley W.

BMJ Open Respir Res. 2018 Jul 11;5(1):e000276. doi: 10.1136/bmjresp-2018-000276. eCollection 2018.

30.

Test Performance Characteristics of the AIR, GAD-7 and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease.

Baker AM, Holbrook JT, Yohannes AM, Eakin MN, Sugar EA, Henderson RJ, Casper AS, Kaminsky DA, Rea AL, Mathews AM, Que LG, Ramsdell JW, Gerald LB, Wise RA, Hanania NA; for American Lung Association Airways Clinical Research Centers.

Ann Am Thorac Soc. 2018 Jul 9. doi: 10.1513/AnnalsATS.201708-631OC. [Epub ahead of print]

PMID:
29986152
31.

Medication Regimens for Managing COPD Exacerbations.

Putcha N, Wise RA.

Respir Care. 2018 Jun;63(6):773-782. doi: 10.4187/respcare.05912. Review.

32.

Clinical characterization of children with resistant airflow obstruction, a multicenter study.

Krishnan S, Dozor AJ, Bacharier L, Lang JE, Irvin CG, Kaminsky D, Farber HJ, Gerald L, Brown M, Holbrook JT, Wise RA, Ryu J, Bose S, Yasin R, Saams J, Henderson RJ, Teague WG; American Lung Association Airway Clinical Research Centers (ALA-ACRC) Network.

J Asthma. 2019 Jun;56(6):611-617. doi: 10.1080/02770903.2018.1477956. Epub 2018 Jun 14.

PMID:
29771599
33.

Performance of the Asthma Impact on Quality of Life Scale (A-IQOLS) in diverse asthma research populations and demographic subgroups.

Wilson SR, Wise RA, Castro M, Mulligan MJ, Ayala E, Chausow A, Huang Q, Gummidipundi S.

J Allergy Clin Immunol. 2019 Jan;143(1):395-402.e7. doi: 10.1016/j.jaci.2018.02.056. Epub 2018 May 4.

PMID:
29729942
34.

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.

Calverley PM, Anzueto AR, Dusser D, Mueller A, Metzdorf N, Wise RA.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 23;13:1297-1308. doi: 10.2147/COPD.S153631. eCollection 2018.

35.

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Martinez FJ, Singh D, Tabberer M, Wise RA, Pascoe SJ; IMPACT Investigators.

N Engl J Med. 2018 May 3;378(18):1671-1680. doi: 10.1056/NEJMoa1713901. Epub 2018 Apr 18.

36.

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.

Putcha N, Paul GG, Azar A, Wise RA, O'Neal WK, Dransfield MT, Woodruff PG, Curtis JL, Comellas AP, Drummond MB, Lambert AA, Paulin LM, Fawzy A, Kanner RE, Paine R 3rd, Han MK, Martinez FJ, Bowler RP, Barr RG, Hansel NN; SPIROMICS investigators.

PLoS One. 2018 Apr 12;13(4):e0194924. doi: 10.1371/journal.pone.0194924. eCollection 2018.

37.

Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.

Wise RA, Chapman KR, Scirica BM, Schoenfeld DA, Bhatt DL, Daoud SZ, Seoane B, Reisner C, Garcia Gil E.

Chronic Obstr Pulm Dis. 2018 Jan 24;5(1):5-15. doi: 10.15326/jcopdf.5.1.2017.0149.

38.

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.

Patel NR, Cunoosamy DM, Fagerås M, Taib Z, Asimus S, Hegelund-Myrbäck T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmér R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P.

Int J Chron Obstruct Pulmon Dis. 2018 Mar 27;13:1009-1019. doi: 10.2147/COPD.S150576. eCollection 2018.

39.

Patterns of Body Composition Relating to Chronic Respiratory Diseases Among Adults in Four Resource-Poor Settings in Peru.

Trompeter G, Grigsby MR, Miele CH, Wise RA, Gilman RH, Miranda JJ, Bernabe-Ortiz A, Checkley W; CRONICAS Cohort Study.

Lung. 2018 Jun;196(3):277-284. doi: 10.1007/s00408-018-0109-7. Epub 2018 Mar 20.

PMID:
29556728
40.

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial.

Wise RA, Calverley PM, Carter K, Clerisme-Beaty E, Metzdorf N, Anzueto A.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 14;13:605-616. doi: 10.2147/COPD.S148393. eCollection 2018.

41.

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.

Fawzy A, Putcha N, Paulin LM, Aaron CP, Labaki WW, Han MK, Wise RA, Kanner RE, Bowler RP, Barr RG, Hansel NN; SPIROMICS and COPDGene Investigators.

Respir Res. 2018 Jan 26;19(1):20. doi: 10.1186/s12931-018-0717-z.

42.

Correction to: electronic cigarette use behaviors and motivations among smokers and non-smokers.

Sussan TE, Shahzad FG, Tabassum E, Cohen JE, Wise RA, Blaha MJ, Holbrook JT, Biswal S.

BMC Public Health. 2018 Jan 24;18(1):175. doi: 10.1186/s12889-018-5048-y.

43.

Asthma and Allergic Disorders in Uganda: A Population-Based Study Across Urban and Rural Settings.

Morgan BW, Siddharthan T, Grigsby MR, Pollard SL, Kalyesubula R, Wise RA, Kirenga B, Checkley W.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1580-1587.e2. doi: 10.1016/j.jaip.2017.11.032. Epub 2018 Feb 1.

44.

Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned.

Ferguson GT, Beck B, Clerisme-Beaty E, Liu D, Thomashow BM, Wise RA, ZuWallack R, Make BJ.

Chronic Obstr Pulm Dis. 2017 Aug 10;4(4):265-278. doi: 10.15326/jcopdf.4.4.2016.0176.

45.

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.

Bhatt SP, Kim YI, Harrington KF, Hokanson JE, Lutz SM, Cho MH, DeMeo DL, Wells JM, Make BJ, Rennard SI, Washko GR, Foreman MG, Tashkin DP, Wise RA, Dransfield MT, Bailey WC; COPDGene Investigators.

Thorax. 2018 May;73(5):414-421. doi: 10.1136/thoraxjnl-2017-210722. Epub 2018 Jan 11.

46.

Association between Household Air Pollution Exposure and Chronic Obstructive Pulmonary Disease Outcomes in 13 Low- and Middle-Income Country Settings.

Siddharthan T, Grigsby MR, Goodman D, Chowdhury M, Rubinstein A, Irazola V, Gutierrez L, Miranda JJ, Bernabe-Ortiz A, Alam D, Kirenga B, Jones R, van Gemert F, Wise RA, Checkley W.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):611-620. doi: 10.1164/rccm.201709-1861OC.

47.

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.

Calverley PM, Tetzlaff K, Dusser D, Wise RA, Mueller A, Metzdorf N, Anzueto A.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 29;12:3391-3405. doi: 10.2147/COPD.S145814. eCollection 2017.

48.

Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.

Parulekar AD, Martinez C, Tsai CL, Locantore N, Atik M, Yohannes AM, Kao CC, Al-Azzawi H, Mohsin A, Wise RA, Foreman MG, Demeo DL, Regan EA, Make BJ, Boriek AM, Wiener LE, Hanania NA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1063-1068. doi: 10.1016/j.jamda.2017.09.028.

49.

The dopamine motive system: implications for drug and food addiction.

Volkow ND, Wise RA, Baler R.

Nat Rev Neurosci. 2017 Nov 16;18(12):741-752. doi: 10.1038/nrn.2017.130. Review.

PMID:
29142296
50.

Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25-75/FVC) in COPD.

Abston E, Comellas A, Reed RM, Kim V, Wise RA, Brower R, Fortis S, Beichel R, Bhatt S, Zabner J, Newell J, Hoffman EA, Eberlein M.

BMJ Open Respir Res. 2017 Oct 13;4(1):e000231. doi: 10.1136/bmjresp-2017-000231. eCollection 2017.

Supplemental Content

Support Center